- About PMI
  - About PMI
    
    Explore PMI Science, where innovation meets harm reduction. Learn about our scientists, smoke-free research, and commitment to transparency in research.
  - PMI Science Booklet
  - Our Scientists
  - The Cube: PMI’s R&D Center
  - PMI’s Global Network
  - Facts and Figures
- Smoke-free approach
  - Smoke-free approach
    
    PMI offers smoke-free alternatives with the potential to reduce the risk of harm for adult smokers who do not quit. Learn about harm reduction, the role of nicotine, and the regulation of smoke-free products.
  - Harm Reduction
  - Absence of Combustion
  - Nicotine
    - Tobacco plant research
  - Cigarette Tar
  - Tobacco regulation
- Research
  - Research
    
    Discover PMI's rigorous scientific approach to smoke-free products and product assessment. Dive into our research results, peer-reviewed publications, independent research, and expert reports.
  - PMI’s studies on smoke-free products
  - Our findings
  - PMI Publications Library
  - Literature reviews
  - Independent studies
  - Investigator Initiated Studies
  - Difference in HPHC levels between cigarette smoke and PMI's THS aerosol
    - HPHC Levels in Heated Tobacco Aerosol: PMI 58 & FDA 93 lists
- Products
  - Products
    
    PMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.
  - Heated tobacco products
    - Tobacco Heating System
    - Oven Heating System
  - E-cigarettes and vaping products
    - Ceramic Vaping System
    - Disposable Vaping System
  - Oral smokeless products
    - Snus
    - Nicotine pouches
  - Nicotine Salts Product
- News & Events
  - News & Events
    
    Explore the latest insights and stay informed about upcoming events and conference presentations from PMI scientists.
  - Scientific Update magazine
  - Open Science events
  - News
  - Conferences calendar
- Contact Us

CONFERENCES

German Pharm-Tox Summit

From 2016 German Pharm-Tox Summit was established together with the German Society for Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie, DGPT), which once a year brings together scientists, academics, researchers, healthcare professionals, regulators, and industry experts to discuss the latest advances in pharmacology, toxicology, and drug development, with topics ranging from clinical pharmacology to environmental toxicology.

Content type

Conference

Date

Mar 13, 2024 - Mar 15, 2024

Location

Munich, Germany

Conference website

Conference description

The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with the Austrian Society of Toxicology (ASTOX), Austrian Pharmacological Society (APHAR) and the Association for Applied Human Pharmacology (AGAH).

Content type

Conference

Date

Mar 02, 2020 - Mar 05, 2020

Conference description

This summit is a joint meeting of the 86th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) with contribution of the Arbeitsgemeinschaft für Angewandte Humanpharmakologie e. V. (AGAH). Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie

See related posters

A Structure-Based Grouping Approach for Evaluating the Toxicity of E-Cigarette Flavor Ingredients: A 5-Week Inhalation Study in A/J Mice

Content type

Conference

Date

Feb 25, 2019 - Feb 28, 2019

Location

Stuttgart, Germany

Conference description

This summit is a joint meeting of the 85th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 21st Annual Meeting of Association of Clinical Pharmacology (VKliPha), in addition to the universities of Tübingen and Ulm.

See related posters

Chronic Toxicity and Lung Carcinogenicity in A/J Mice Following Lifetime Exposure to Aerosol from a Candidate Modified Risk Tobacco Product and Mainstream Cigarette Smoke

See related presentations

Tabakerhitzer (Heat-not-Burn): Das Potenzial für Harm Reduction

Content type

Conference

Date

Mar 15, 2005 - Mar 17, 2005

Location

Mainz, Germany

Conference description

This is the 46th Spring Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology.

See related posters

Enhanced Lung Tumorigenicity in the A/J Mouse after Inhalation of Cigarette Mainstream Smoke and Gas Phase-Depleted Particle Phase

Content type

Conference

Date

Mar 13, 2005 - Mar 15, 2005

Location

Mainz, Germany

Conference description

This is the 48th Spring Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology.

See related posters

Enhanced Lung Tumorigenicity in the A/J Mouse after Inhalation of Cigarette Mainstream Smoke and Gas Phase-Depleted Particle Phase

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.

German Pharm-Tox Summit

9th German Pharm-Tox Summit 2024

5th German Pharm-Tox Summit 2020

See related posters

4th German Pharm-Tox Summit 2019

See related posters

See related presentations

DGPT Annual Meeting 2005

See related posters

DGPT Annual Meeting 2007

See related posters